Peter S. Kim, Director at Entrada Therapeutics, Inc. (TRDA), bought 4,476 shares at $14.25 ($63K) on 2024-05-09, disclosed to the SEC on 2024-05-10.
Open-market purchase of $63k TRDA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.04 | 2,276 | $32K | 50.5% |
| 2 | $14.25 | 2,200 | $31K | 49.5% |
| Total | $14.14 avg | 4,476 | $63K | 100% |
| Filing → |
| TRDA | BUY | 2024-04-10 | $35K | — | Filing → |
| TRDA | BUY | 2024-04-01 | $21K | — | Filing → |
| TRDA | BUY | 2024-03-26 | $123K | — | Filing → |